Bank of New York Mellon Corp Increases Position in Agilent Technologies, Inc. (A)

Bank of New York Mellon Corp boosted its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 1.5% during the second quarter, Holdings Channel reports. The fund owned 5,721,557 shares of the medical research company’s stock after buying an additional 84,801 shares during the period. Bank of New York Mellon Corp’s holdings in Agilent Technologies were worth $339,346,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in A. State of Wisconsin Investment Board boosted its stake in Agilent Technologies by 53.4% in the second quarter. State of Wisconsin Investment Board now owns 501,295 shares of the medical research company’s stock valued at $29,732,000 after buying an additional 174,490 shares during the last quarter. LMR Partners LLP purchased a new stake in Agilent Technologies during the second quarter valued at approximately $2,384,000. Advisors Asset Management Inc. boosted its stake in Agilent Technologies by 5.6% in the second quarter. Advisors Asset Management Inc. now owns 54,757 shares of the medical research company’s stock valued at $3,248,000 after buying an additional 2,925 shares during the last quarter. Smith Asset Management Group LP purchased a new stake in Agilent Technologies during the second quarter valued at approximately $25,593,000. Finally, Teacher Retirement System of Texas purchased a new stake in Agilent Technologies during the second quarter valued at approximately $200,000.

Agilent Technologies, Inc. (A) opened at 60.86 on Friday. The firm has a market capitalization of $19.60 billion, a price-to-earnings ratio of 31.39 and a beta of 1.30. The company’s 50 day moving average price is $60.23 and its 200-day moving average price is $56.04. Agilent Technologies, Inc. has a 12-month low of $42.92 and a 12-month high of $62.42.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Tuesday, August 15th. The medical research company reported $0.59 EPS for the quarter, topping the Zacks’ consensus estimate of $0.52 by $0.07. The business had revenue of $1.11 billion for the quarter, compared to analyst estimates of $1.09 billion. Agilent Technologies had a return on equity of 16.95% and a net margin of 14.36%. Agilent Technologies’s quarterly revenue was up 6.7% compared to the same quarter last year. During the same period last year, the company posted $0.49 earnings per share. On average, equities analysts anticipate that Agilent Technologies, Inc. will post $2.31 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: “Bank of New York Mellon Corp Increases Position in Agilent Technologies, Inc. (A)” was posted by Community Financial News and is the property of of Community Financial News. If you are reading this story on another domain, it was illegally stolen and republished in violation of US & international copyright & trademark laws. The legal version of this story can be read at https://www.com-unik.info/2017/08/18/bank-of-new-york-mellon-corp-increases-position-in-agilent-technologies-inc-a.html.

Several equities research analysts have commented on the company. Bank of America Corporation boosted their target price on Agilent Technologies from $66.00 to $68.00 and gave the company an “equal weight” rating in a research note on Wednesday. Morgan Stanley restated an “overweight” rating on shares of Agilent Technologies in a research note on Wednesday. Deutsche Bank AG set a $68.00 target price on Agilent Technologies and gave the company a “buy” rating in a research note on Wednesday. Janney Montgomery Scott boosted their target price on Agilent Technologies from $65.00 to $70.00 and gave the company a “buy” rating in a research note on Wednesday. Finally, J P Morgan Chase & Co restated an “overweight” rating and issued a $70.00 target price on shares of Agilent Technologies in a research note on Wednesday. Three equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $62.55.

In other Agilent Technologies news, insider Dominique Grau sold 13,007 shares of the business’s stock in a transaction on Wednesday, August 16th. The stock was sold at an average price of $62.00, for a total value of $806,434.00. Following the sale, the insider now directly owns 60,098 shares in the company, valued at $3,726,076. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Didier Hirsch sold 5,710 shares of the business’s stock in a transaction on Thursday, June 1st. The shares were sold at an average price of $60.60, for a total value of $346,026.00. The disclosure for this sale can be found here. Insiders have sold 125,615 shares of company stock worth $7,543,943 over the last quarter.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

What are top analysts saying about Agilent Technologies Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Agilent Technologies Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit